Wellbutrin and Hepatic mass - a phase IV clinical study of FDA data

Summary:

Hepatic mass is reported as a side effect among people who take Wellbutrin (bupropion hydrochloride), especially for people who are female, 50-59 old, also take Prozac, and have Metastases to bone.

The phase IV clinical study analyzes which people have Hepatic mass when taking Wellbutrin. It is created by eHealthMe based on reports of 101,581 people who have side effects when taking Wellbutrin from the FDA, and is updated regularly.

What is Wellbutrin?

Wellbutrin has active ingredients of bupropion hydrochloride. It is often used in depression. eHealthMe is studying from 117,115 Wellbutrin users. Check the latest studies of Wellbutrin.

What is Hepatic mass?

Hepatic mass is found to be associated with 400 drugs and 378 conditions by eHealthMe. Check the latest studies of Hepatic mass.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

101,581 people reported to have side effects when taking Wellbutrin.
Among them, 31 people (0.03%) have Hepatic mass.

Among these 31 people:

What is the gender of people who have Hepatic mass when taking Wellbutrin? *

female: 80.65 %
male: 19.35 %

What is the age of people who have Hepatic mass when taking Wellbutrin? *

What are other drugs people take besides Wellbutrin? *

What are other side effects people have besides Hepatic mass? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 20 people, 64.52%
Intervertebral Disc Protrusion (spinal disc protrusion): 19 people, 61.29%
Anaemia (lack of blood): 19 people, 61.29%
Memory Loss: 19 people, 61.29%
Weight Increased: 18 people, 58.06%
Chest Pain: 18 people, 58.06%
Abdominal Pain Upper: 18 people, 58.06%
Indigestion: 18 people, 58.06%
Pain: 18 people, 58.06%
Swallowing Difficulty: 18 people, 58.06%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 16 people, 51.61%
High Blood Pressure: 3 people, 9.68%
Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 9.68%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 9.68%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 9.68%
High Blood Cholesterol: 3 people, 9.68%
Breast Cancer Metastatic: 2 people, 6.45%
Thyroid Diseases: 2 people, 6.45%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.45%
Analgesic Effect: 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Wellbutrin and have Hepatic mass?

- Check whether Hepatic mass is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Wellbutrin:

Wellbutrin (117,115 reports)

Hepatic mass treatments and more:

Hepatic mass (2,425 reports)

Browse all side effects of Wellbutrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic mass:

Hepatic mass (400 drugs)

Browse all the conditions that are associated with Hepatic mass:

Hepatic mass (378 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bupropion hydrochloride (the active ingredients of Wellbutrin) and Wellbutrin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.